This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0405U only for BTG Early Detection of Pancreatic Cancer from Breakthrough Genomics. The test uses a plasma specimen to evaluate circulating tumor cell–free DNA (cfDNA) for 59 biomarkers described in the code to help detect early pancreatic cancer in patients at high risk for developing the disease.
For clinical responsibility, terminology, tips and additional info
start codify free trial.